FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

More evidence links physical activity with improved cancer survival

2.

Base-edited T-cell therapy offers additional hope for treating resistant leukemia.

3.

Ultrasound bras; HPV and thyroid cancer; language minimizing adverse events.

4.

In schizophrenia, sexual dysfunction is frequent.

5.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot